Selahattin Çolakoğlu

Selahattin Colakoglu serves as the Clinical Development Lead at Albert Health since August 2021, where responsibilities include the development and execution of clinical trials, regulatory strategy and compliance, data collection and analysis, publication and dissemination of results, cross-functional collaboration, and engagement with patients and healthcare providers. Prior to this role, Selahattin Colakoglu held various positions at GSK from August 2019 to August 2021, including Medical Lead, Medical FLP, and Medical Science Liaison, focusing on clinical development and medical project support. Selahattin Colakoglu earned a Doctor of Medicine (MD) degree from Dokuz Eylul University from 2012 to 2019 and completed secondary education at Aydın Fen Lisesi from 2008 to 2012.